# ClinicalTrials.gov record NCT00035256

> PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00035256-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2007-05-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00035256-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00035256-teriparatide-v1.json
- Content SHA-256: `77b44682af715e36b7f3610844f4923f3831941acc682fd53d606bde6f3e4af9`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00035256 ([`ctg-observation-nct00035256-2007-05-15-8f826c50b13e`](#source-ctg-observation-nct00035256-2007-05-15-8f826c50b13e))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00035256-2007-05-15-8f826c50b13e`](#source-ctg-observation-nct00035256-2007-05-15-8f826c50b13e))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00035256-2007-05-15-8f826c50b13e`](#source-ctg-observation-nct00035256-2007-05-15-8f826c50b13e))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00035256-2007-05-15-8f826c50b13e`](#source-ctg-observation-nct00035256-2007-05-15-8f826c50b13e))

## Sources

<a id="source-ctg-observation-nct00035256-2007-05-15-8f826c50b13e"></a>
- **ClinicalTrials.gov record NCT00035256 · retained source version 2007-05-15:8f826c50b13e136db1f79be7f1014d618137b187f79ba83add3898b8f57e38e5** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00035256) (`ctg-observation-nct00035256-2007-05-15-8f826c50b13e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00035256." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00035256-teriparatide-v1.json SHA-256: 77b44682af715e36b7f3610844f4923f3831941acc682fd53d606bde6f3e4af9.